v3.20.4
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
 3 Months Ended 6 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Dec. 31, 2020
Dec. 31, 2019
Revenues        
Total Revenues $ 798,793 $ 876,529 $ 1,977,006 $ 1,501,426
Cost of Sales        
Total Cost of Sales 471,063 492,105 1,304,240 985,784
Gross Profit 327,730 384,424 672,766 515,642
General and Administrative Expenses        
Stock compensation and stock issued for services 13,200 679,881 2,776,200 2,007,692
General and administrative 1,257,918 1,805,480 2,650,145 2,601,528
Total General and Administrative Expenses 1,271,118 2,485,361 5,426,345 4,609,220
Loss from Operations (943,388) (2,100,937) (4,753,579) (4,093,578)
Other Income (Expense)        
Other income 3,049
Expenses related to convertible notes payable:        
Change in fair value of derivative liability (2,442,688) 1,219,289 (3,496,583) 2,022,257
Interest accretion (366,667) (579,920) (766,603) (808,853)
Interest expense related to Equity Purchase Agreement (Note 13) (995,000) (5,001,900)
Interest expense (3,020,338) (1,360,639) (6,884,194) (1,962,429)
Total Other Income (Expense) (6,824,693) (721,270) (16,149,280) (745,976)
Net Loss before Income Taxes (7,768,081) (2,822,207) (20,902,859) (4,839,554)
Income taxes (Note 11)
Net Loss $ (7,768,081) $ (2,822,207) $ (20,902,859) $ (4,839,554)
Net Basic and Fully Diluted Loss Per Share $ (0.003) $ (0.161) $ (0.011) $ (0.331)
Weighted average common shares outstanding        
Basic 2,314,084,953 17,531,574 1,978,500,180 14,636,414
Fully diluted 2,776,901,944 27,349,020 3,205,073,044 31,849,788